MRSI-based molecular imaging of therapy response to temozolomide in preclinical glioblastoma using source analysis-Reference-Cited by-同舟云学术

MRSI-based molecular imaging of therapy response to temozolomide in preclinical glioblastoma using source analysis

Published:2016-04-08 Issue:6 Volume:29 Page:732-743
ISSN:0952-3480
Container-title:NMR in Biomedicine
language:en
Short-container-title:NMR Biomed.

Author:

Delgado-Goñi T.¹²³,Ortega-Martorell S.⁴²,Ciezka M.¹²⁵,Olier I.⁶⁷,Candiota A. P.²¹⁵,Julià-Sapé M.²¹⁵^ORCID,Fernández F.⁸²,Pumarola M.⁸²,Lisboa P. J.⁴,Arús C.¹²⁵

Affiliation:

1. Departament de Bioquímica i Biologia Molecular; Universitat Autònoma de Barcelona; Cerdanyola del Vallès Spain

2. Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN); Universitat Autònoma de Barcelona; Cerdanyola del Vallès Spain

3. Division of Radiotherapy and Imaging; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust; Sutton Surrey UK

4. Department of Mathematics and Statistics; Liverpool John Moores University; Liverpool UK

5. Institut de Biotecnologia i de Biomedicina; Universitat Autònoma de Barcelona; Cerdanyola del Vallès Spain

6. Institute for Science and Technology in Medicine; Keele University; Stoke-On-Trent UK

7. Centre for Health Informatics; Institute of Population Health University of Manchester; Manchester UK

8. Departament de Medicina i Cirurgia Animals; Universitat Autònoma de Barcelona; Cerdanyola del Vallès Spain

Funder

MINECO

MOLIMAGLIO

Publisher

Wiley

Subject

Spectroscopy,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference51 articles.

1. Glioblastoma in adults;Brandes;Crit. Rev. Oncol. Hematol.,2008

2. Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas;Rhee;Clin. Neurol. Neurosurg.,2009

3. Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression;Neal;Cancer Res.,2013

4. Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging;Suh;Am. J. Neuroradiol.,2013

5. Diffusion MR imaging of the brain in patients with cancer;Debnam;Int. J. Mol. Imaging,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early pseudoprogression and progression lesions in glioblastoma patients are both metabolically heterogeneous;NMR in Biomedicine;2024-01-11

2. Correlation of MR-Based Metabolomics and Molecular Profiling in the Tumor Microenvironment of Temozolomide-Treated Orthotopic GL261 Glioblastoma in Mice;International Journal of Molecular Sciences;2023-12-18

3. Tracking Therapy Response in Glioblastoma Using 1D Convolutional Neural Networks;Cancers;2023-08-07

4. Lipid Alterations in Glioma: A Systematic Review;Metabolites;2022-12-16

5. Metabolic changes in glioblastomas in response to choline kinase inhibition: In vivo MRS in rodent models;NMR in Biomedicine;2022-11-10